Pipeline

*This table can be scrolled horizontally

Developed product

Mechanism/target

Cancer type

Discovery

Preclinical

PI

PII

_Cell Therapy

iPS cell-derived NKT cells

HNSCC

CAR-iPSNKT(Undisclosed)

Hematologic
Malignancy

HER2 CAR-T

Sarcoma,
Gynecological
Tumors

_Antibody

CD73

CD39

TIM3

CD39 × TIM3

CD39 × CD3

Acute Myeloid
Leukemia

_Cancer Vaccine

Personalized Neoantigen

Solid Tumor

Page Top